Goulbourne, C., & Vaux, D. (2010). HIV protease inhibitors inhibit FACE1/ZMPSTE24: A mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy? Portland Press.
Chicago Style (17th ed.) CitationGoulbourne, C., and D. Vaux. HIV Protease Inhibitors Inhibit FACE1/ZMPSTE24: A Mechanism for Acquired Lipodystrophy in Patients on Highly Active Antiretroviral Therapy? Portland Press, 2010.
MLA citiranjeGoulbourne, C., and D. Vaux. HIV Protease Inhibitors Inhibit FACE1/ZMPSTE24: A Mechanism for Acquired Lipodystrophy in Patients on Highly Active Antiretroviral Therapy? Portland Press, 2010.
Opozorilo: Ti citati niso vedno 100% točni.